Revenue and profitability grew strongly in H1 FY'26, with PAT up 66% HoH and gross profit up 38.2%, driven by diversification and technology innovation. Despite a sharp decline in DMT business, alternate products and AI-driven solutions supported resilient growth.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.